BMRC
Bank of Marin Bancorp
BMRC's fundamentals are strong and it looks cheap: trading at 6.8x earnings, about half its usual 14x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BMRC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
BMRC's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like BMRC.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BMRC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.8x | $28.52 | — |
| Cheap | 8.8x | $37.00 | +30% |
| Forward | 11x | $28.52 | — |
| Fair | 14x | $57.55 | +102% |
| Expensive | 18x | $75.08 | +163% |
Historical ranges are pointers, not guarantees.
BMRC's PE is in its cheap range at 6.8x. On analysts' estimates for next year's earnings, today's price would be 11x.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BMRC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BMRC has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BMRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.50 | -41% |
| Q3 2026 | $4.22 | +581% |
| Q2 2026 | $4.07 | +847% |
| Q1 2026 | $2.96 | +$3.36 |
| Q4 2025 | $2.73 | +$3.25 |
| Q3 2025 | $0.62 | +$1.48 |
| Q2 2025 | $0.43 | +$1.24 |
| Q1 2025 | -$0.40 | -148% |
| Q4 2024 | -$0.52 | -142% |
BMRC has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BMRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.1M | +13% |
| Q2 2026 | $34M | +230% |
| Q1 2026 | $34.1M | +23% |
| Q4 2025 | $79.3M | +183% |
| Q3 2025 | $30.9M | +14% |
| Q2 2025 | $10.3M | +181% |
| Q1 2025 | $27.8M | +9.3% |
| Q4 2024 | $28M | +33% |
BMRC's revenue has grown year over year for nine quarters in a row: $35M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +7.9 points |
| Q2 2026 | 37% | +146 points |
| Q1 2026 | 34% | +11 points |
| Q4 2025 | 59% | +25 points |
| Q3 2025 | 31% | +5.4 points |
| Q2 2025 | -109% | +830 points |
| Q1 2025 | 23% | +7.9 points |
| Q4 2024 | 34% | +33 points |
BMRC has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
BMRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16M | +33% |
| Q2 2026 | $11.8M | +68% |
| Q1 2026 | $921K | -80% |
| Q4 2025 | $13.2M | +25% |
| Q3 2025 | $12.1M | +24% |
| Q2 2025 | $7.1M | +111% |
| Q1 2025 | $4.6M | +11% |
| Q4 2024 | $10.6M | +1261% |
BMRC has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BMRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +49K shares |
| 1 year | +0.7% | +106K shares |
| 3 years | 0% | +4K shares |
| 5 years | +7% | +1M shares |
| Available history | +16% | +2.2M shares |
BMRC has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $6,000 |
| Q1 2026 | $6,000 |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q4 2024 | $19,000 |
| Q2 2024 | $55,000 |
| Q4 2023 | — |
BMRC has spent almost nothing on buybacks in the past year.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BMRC Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BMRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.3 | Neutral |
| Stochastic | 61.9 | Neutral |
BMRC's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BMRC PE vs Financial Services Sector
| Metric | BMRC | Sector median | Relative |
|---|---|---|---|
| PE | 6.8x | 13x | 48% below |
| PE % | 6 | 63 | 57 pts below |
BMRC is trading at 6.8x earnings, a 48% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
BMRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 3.2% above |
| 20 week MA | $27.9 | 2.1% above |
| 50 week MA | $26.9 | 6.1% above |
| 100 week MA | $25.1 | 13% above |
| 200 week MA | $22.6 | 26% above |
BMRC has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BMRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.0 | $36.5 | -21% |
| 2021 | $36.5 | $36.6 | +0.4% |
| 2022 | $36.6 | $33.0 | -9.9% |
| 2023 | $33.0 | $22.0 | -33% |
| 2024 | $22.0 | $23.5 | +6.8% |
| 2025 | $23.5 | $26.6 | +13% |
| 2026 YTD | $26.6 | $28.5 | +7.3% |
BMRC has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.